Journal article
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
- Abstract:
-
Background
The evidence for whether ivermectin impacts recovery, hospital admissions, and longer-term outcomes in COVID-19 is contested. The WHO recommends its use only in the context of clinical trials.
Methods
In this multicentre, open-label, multi-arm, adaptive platform randomised controlled trial, we included participants aged ≥18 years in the community, with a positive SARS-CoV-2 test, and symptoms lasting ≤14 days. Participants were randomi... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.9MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.jinf.2024.106130
Bibliographic Details
- Publisher:
- Elsevier
- Journal:
- Journal of Infection More from this journal
- Volume:
- 88
- Issue:
- 4
- Article number:
- 106130
- Place of publication:
- England
- Publication date:
- 2024-02-29
- Acceptance date:
- 2024-02-22
- DOI:
- EISSN:
-
1532-2742
- ISSN:
-
0163-4453
- Pmid:
-
38431155
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
1681444
- Local pid:
-
pubs:1681444
- Deposit date:
-
2024-03-20
Terms of use
- Copyright holder:
- Hayward et al
- Copyright date:
- 2024
- Rights statement:
- © 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record